NANOVIRICIDES, INC. Earnings Per Share (Basic)
NANOVIRICIDES, INC. (NNVC) reported Earnings Per Share (Basic) of -$0.09 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-15
- NANOVIRICIDES, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.09.
- NANOVIRICIDES, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.11.
- NANOVIRICIDES, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.10.
- NANOVIRICIDES, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.14.
- NANOVIRICIDES, INC. earnings per share, basic for fiscal 2025 was -$0.63.
- NANOVIRICIDES, INC. earnings per share, basic for fiscal 2024 was -$0.70.
- NANOVIRICIDES, INC. earnings per share, basic for fiscal 2023 was -$0.74.
- NANOVIRICIDES, INC. earnings per share, basic for fiscal 2022 was -$0.70.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$0.09 10-Q · filed 2026-05-15 | -$0.31 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | -$0.11 10-Q · filed 2026-02-17 | -$0.22 10-Q · filed 2026-02-17 | ||
| 2025-09-30 | -$0.10 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$0.63 10-K · filed 2025-09-29 | |||
| 2025-03-31 | -$0.14 10-Q · filed 2026-05-15 | -$0.50 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | -$0.14 10-Q · filed 2026-02-17 | -$0.36 10-Q · filed 2026-02-17 | ||
| 2024-09-30 | -$0.23 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$0.70 10-K · filed 2025-09-29 | |||
| 2024-03-31 | -$0.16 10-Q · filed 2025-05-15 | -$0.51 10-Q · filed 2025-05-15 | ||
| 2023-12-31 | -$0.18 10-Q · filed 2025-02-14 | -$0.35 10-Q · filed 2025-02-14 | ||
| 2023-09-30 | -$0.17 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$0.74 10-K · filed 2024-09-27 | |||
| 2023-03-31 | -$0.15 10-Q · filed 2024-05-15 | -$0.43 10-Q · filed 2024-05-15 | ||
| 2022-12-31 | -$0.15 10-Q · filed 2024-02-14 | -$0.29 10-Q · filed 2024-02-14 | ||
| 2022-09-30 | -$0.14 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$0.70 10-K · filed 2023-10-13 | |||
| 2022-03-31 | -$0.16 10-Q · filed 2023-05-15 | -$0.55 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | -$0.17 10-Q · filed 2023-02-14 | -$0.39 10-Q · filed 2023-02-14 | ||
| 2021-09-30 | -$0.23 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$0.81 10-K · filed 2022-10-13 | |||
| 2021-03-31 | -$0.19 10-Q · filed 2022-05-16 | -$0.63 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | -$0.22 10-Q · filed 2022-02-14 | -$0.44 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | -$0.22 10-Q · filed 2021-11-15 | |||
| 2018-06-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.06 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.10 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.13 10-K · filed 2018-10-12 |
| 2018-03-31 | -$0.03 10-Q · filed 2018-05-21 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-05-21 | -$0.11 10-Q · filed 2018-05-21 | -$0.15 derived: net income ÷ weighted average shares · filed 2018-10-12 |
| 2017-12-31 | -$0.04 10-Q · filed 2018-02-20 | -$0.08 10-Q · filed 2018-02-20 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-10-12 |
| 2017-09-30 | -$0.03 10-Q · filed 2017-11-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2018-10-12 |
| 2017-06-30 | -$0.04 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.09 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.17 10-K · filed 2018-10-12 |
| 2017-03-31 | -$0.05 10-Q · filed 2018-05-21 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-05-21 | -$0.13 10-Q · filed 2018-05-21 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-10-12 |
| 2016-12-31 | -$0.03 10-Q · filed 2018-02-20 | -$0.08 10-Q · filed 2018-02-20 | -$0.11 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.19 derived: net income ÷ weighted average shares · filed 2018-10-12 |
| 2016-09-30 | -$0.05 10-Q · filed 2017-11-14 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.22 derived: net income ÷ weighted average shares · filed 2018-10-12 |
| 2016-06-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.11 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-10-12 | -$0.19 10-K · filed 2018-10-12 |
| 2016-03-31 | -$0.09 10-Q · filed 2017-05-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2017-05-15 | -$0.16 10-Q · filed 2017-05-15 | -$0.17 derived: net income ÷ weighted average shares · filed 2017-09-28 |
| 2015-12-31 | -$0.05 10-Q · filed 2017-02-14 | -$0.07 10-Q · filed 2017-02-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2017-09-28 | -$0.09 derived: net income ÷ weighted average shares · filed 2017-09-28 |
| 2015-09-30 | -$0.02 10-Q · filed 2016-11-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-09-28 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-09-28 | -$0.08 derived: net income ÷ weighted average shares · filed 2017-09-28 |
| 2015-06-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-09-28 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-09-28 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-09-28 | -$0.04 10-K · filed 2017-09-28 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | -$0.04 derived: net income ÷ weighted average shares · filed 2016-05-10 | -$0.02 10-Q · filed 2016-05-10 | -$0.15 derived: net income ÷ weighted average shares · filed 2016-09-16 |
| 2014-12-31 | -$0.03 10-Q · filed 2016-02-09 | -$0.02 10-Q · filed 2016-02-09 | -$0.15 derived: net income ÷ weighted average shares · filed 2016-09-16 | -$0.12 derived: net income ÷ weighted average shares · filed 2016-09-16 |
| 2014-09-30 | $0.02 10-Q · filed 2015-11-09 | -$0.11 derived: net income ÷ weighted average shares · filed 2016-09-16 | -$0.09 derived: net income ÷ weighted average shares · filed 2016-09-16 | -$0.12 derived: net income ÷ weighted average shares · filed 2016-09-16 |
| 2014-06-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-09-16 | -$0.11 derived: net income ÷ weighted average shares · filed 2016-09-16 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-09-16 | -$0.27 10-K · filed 2016-09-16 |
| 2014-03-31 | $0.02 10-Q · filed 2015-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$0.13 10-Q · filed 2015-05-15 | |
| 2013-12-31 | -$0.03 10-Q · filed 2015-02-25 | -$0.16 10-Q · filed 2015-02-25 | ||
| 2013-06-30 | -$0.19 10-K · filed 2015-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |